NFKB1 and gingival cancer: Anethole (3 μM) potentiated cisplatin-induced inhibition of Ca9-22 gingival cancer cells, reduced cell viability, increased apoptosis and inhibited key cancer signaling pathways including MAPK, β-catenin and NF-κB.